ASPIRA PATHLAB & DIAGNOSTICS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 32.5 INR | +1.56% |
|
+8.05% | -17.05% |
| Apr. 03 | Aspira Pathlab Forms New Limited Liability Partnership | MT |
| Apr. 01 | Aspira Pathlab Opens Two Diagnostic Centers in India | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Aspira Pathlab & Diagnostics Limited is an India-based company, which is engaged in the business of running, owning, managing, and administering Diagnostics Centers. The principal activities of the Company consist of pathology investigation services, radiology investigation services and other related healthcare services at diagnostic centers in Mumbai. The Company carries out pathological investigations in various branches, including biochemistry, hematology, histopathology, microbiology, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. The Company's tests include COVID-19 tests, health packages and pathology tests. Its COVID-19 tests include Shanti Screening Test, COVID-19 Antibody Test, COVID-19 Surveillance Profile, COVID-19 RT-PCR Test, COVID-19 Detection Profile 1, and COVID-19 Detection Profile 2.
Calendar
2024-05-29
- Q4 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -17.05% | 3.95M | |
| -17.58% | 8.43B | |
| +39.49% | 3.62B | |
| -38.71% | 2.61B | |
| -8.06% | 2.48B | |
| -7.96% | 2.34B | |
| -13.97% | 1.94B | |
| -19.73% | 1.56B | |
| -40.78% | 1.26B | |
| +8.32% | 1.1B |
- Stock Market
- Equities
- 540788 Stock
- News Aspira Pathlab & Diagnostics Limited
- Aspira Pathlab Forms New Limited Liability Partnership
